PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

(-)-Myrtenol accelerates healing of acetic acid-induced gastric ulcers in rats and in human gastric adenocarcinoma cells.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30991046 ↗2019Reported benefit

(-)-Myrtenol accelerates healing of acetic acid-induced gastric ulcers in rats and in human gastric adenocarcinoma cells.

RatChemical/toxinWistarmaleoral administration50 and 100 mg/kg/dayafter ulcer induction, as treatment of the established chronic gastric ulcer

Model: Chronic gastric ulcer induced by serosal injection of 80% acetic acid

Oral (-)-myrtenol at 50 and 100 mg/kg/day for 7 days significantly decreased ulcer area and volume compared with vehicle-treated ulcer controls, with increased gastric mucin, collagen deposition and PCNA-positive cells, altered TNF-alpha, IL-1beta and COX-2 expression and reduced MMP-9 and MMP-2 ac…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.